Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alina Striha"'
Autor:
Graham H. Jackson, Faith E. Davies, Charlotte Pawlyn, David A. Cairns, Alina Striha, Corinne Collett, Anna Waterhouse, John R. Jones, Bhuvan Kishore, Mamta Garg, Cathy D. Williams, Kamaraj Karunanithi, Jindriska Lindsay, David Allotey, Salim Shafeek, Matthew W. Jenner, Gordon Cook, Nigel H. Russell, Martin F. Kaiser, Mark T. Drayson, Roger G. Owen, Walter M. Gregory, Gareth J. Morgan, UK NCRI Haematological Oncology Clinical Studies Group
Publikováno v:
Haematologica, Vol 106, Iss 7 (2020)
The optimal way to use immunomodulatory drugs as components of induction and maintenance therapy for multiple myeloma is unresolved. We addressed this question in a large phase III randomized trial, Myeloma XI. Patients with newly diagnosed multiple
Externí odkaz:
https://doaj.org/article/ac9102e2744b4ca5875fa85833c07ea6
Autor:
Alina Striha, A. John Ashcroft, Anna Hockaday, David A. Cairns, Karen Boardman, Gwen Jacques, Cathy Williams, John A. Snowden, Mamta Garg, Jamie Cavenagh, Kwee Yong, Mark T. Drayson, Roger Owen, Mark Cook, Gordon Cook
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-14 (2018)
Abstract Background Multiple myeloma (MM) is a plasma cell tumour with an approximate annual incidence of 4500 in the UK. Therapeutic options for patients with MM have changed in the last decade with the arrival of proteasome inhibitors and immunomod
Externí odkaz:
https://doaj.org/article/a804debd98c54c009c1516a296fbdf16
Autor:
Kamaraj Karunanithi, Charlotte Pawlyn, Nigel H. Russell, Walter M Gregory, Alina Striha, Cathy D. Williams, Mamta Garg, Gareth J. Morgan, Craig Taylor, Matthew W Jenner, Jamie Wilson, Corinne Collett, Martin Kaiser, Roger G. Owen, Anna Waterhouse, Bhuvan Kishore, Faith E. Davies, John R Jones, Mark T. Drayson, David A Cairns, Jindriska Lindsay, Gordon Cook, Graham Jackson
Publikováno v:
British journal of haematologyReferences. 192(5)
Second-generation immunomodulatory agents, such as lenalidomide, have a more favourable side-effect profile than the first-generation thalidomide, but their optimum combination and duration for patients with newly diagnosed transplant-ineligible myel
Autor:
null Graham H. Jackson, null Faith E. Davies, null Charlotte Pawlyn, null David A. Cairns, null Alina Striha, null Corinne Collett, null Anna Waterhouse, null John R. Jones, null Bhuvan Kishore, null Mamta Garg, null Cathy D. Williams, null Kamaraj Karunanithi, null Jindriska Lindsay, null David Allotey, null Salim Shafeek, null Matthew W. Jenner, null Gordon Cook, null Nigel H. Russell, null Martin F. Kaiser, null Mark T. Drayson, null Roger G. Owen, null Walter M. Gregory, null Gareth J. Morgan, null UK NCRI Haematological Oncology Clinical Studies Group
Publikováno v:
Haematologica
The optimal way to use immunomodulatory drugs as components of induction and maintenance therapy for multiple myeloma is unresolved. We addressed this question in a large phase III randomized trial, Myeloma XI. Patients with newly diagnosed multiple
Autor:
Charlotte Pawlyn, Alina Striha, Mark T. Drayson, de, Tute, Rm, John R Jones, Walter M Gregory, David A Cairns, Andy C. Rawstron, Martin Kaiser, Graham Jackson, G. J. Morgan, Faith E. Davies, Anna Chalmers, Graham P. Cook, Roger G. Owen, Corinne Collett, Nigel H. Russell
Publikováno v:
British Journal of Haematology. 173:5-178
Autor:
Graham Jackson, Alina Striha, David A Cairns, Mark T. Drayson, Anna Hockaday, Nigel H. Russell, Matthew Jenner, Gareth J. Morgan, Charlotte Pawlyn, Andy C. Rawstron, Gordon Cook, Martin Kaiser, Roger G. Owen, Faith E. Davies, John R Jones, Ruth M. de Tute, Walter M Gregory
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e45-e46
Autor:
Alina Striha, Martin Kaiser, John R Jones, Kamaraj Karunanithi, Faith E. Davies, Walter M Gregory, David A Cairns, Cathy Williams, Charlotte Pawlyn, Mark T. Drayson, Roger G. Owen, Jindriska Lindsay, Matthew Jenner, Gordon Cook, Graham Jackson, Anna Hockaday, Bhuvan Kishore, Gareth J. Morgan, Mamta Garg, Nigel H. Russell
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e2
Autor:
Martin Kaiser, Mark T. Drayson, G. J. Morgan, Kamaraj Karunanithi, C. Pawlyn, Alina Striha, David A Cairns, Roger G. Owen, Graham H. Jackson, Matthew Jenner, Mamta Garg, Cathy D. Williams, John R Jones, Bhuvan Kishore, W Gregory, Anna Hockaday, F. Davies, Gary Cook, N. Russell, Jindriska Lindsay
Publikováno v:
HemaSphere. 3:391
Autor:
David A Cairns, John Ashcroft, Mamta Garg, John A. Snowden, Mark T. Drayson, Roger G. Owen, Mark J. Cook, Cathy Williams, Christopher Parrish, Gordon Cook, Ruth M. de Tute, Kwee Yong, Anna Hockaday, Jamie Cavenagh, Alina Striha
Publikováno v:
Blood. 132:255-255
Introduction: Salvage autologous transplantation (sASCT) in multiple myeloma has been shown to induce superior durability of responses over low-dose alkylating consolidation therapy in the relapsed setting1. The optimum re-induction regimen leading t
Autor:
Roger G. Owen, David A Cairns, Alina Striha, Mamta Garg, John R Jones, Matthew W Jenner, Mark T. Drayson, Graham Jackson, Kamaraj Karunanithi, Ceri Bygrave, Gareth J. Morgan, Cathy Williams, Charlotte Pawlyn, Martin Kaiser, Jindriska Lindsay, Gordon Cook, Andrea Paterson, Anna Hockaday, Nigel H Russel, Walter M Gregory, Faith E. Davies, Bhuvan Kishore
Publikováno v:
Blood. 132:122-122
Introduction Multi-agent induction chemotherapy followed by autologous stem cell transplant (ASCT) is a standard of care for younger patients with multiple myeloma, aimed at maximising the depth and duration of first response (PFS1). However, the dur